🇺🇸 FDA
Patent

US 11384055

Glycolate oxidase inhibitors for the treatment of disease

granted A61PA61P13/00

Quick answer

US patent 11384055 (Glycolate oxidase inhibitors for the treatment of disease) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P13/00